SHERIE HILDRETH OVARIAN CANCER FOUNDATION (EIN 562497219) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2005

Legal Domicile

Principal Officer

BRUCE HILDRETH

Phone

5038195310

Tax Period

2024-01-01 to 2024-12-31

SHERIE HILDRETH OVARIAN CANCER FOUNDATION, founded in 2005, is a micro nonprofit in the Diseases & Disorders sector that reported $34K in total revenue in fiscal year 2024. Revenue surged 59% from the prior year, signaling strong growth momentum. The organization ran a surplus of $22K, a strong 64% operating margin.

Mission

TO PROVIDE FUNDING FOR OVARIAN CANCER RESEARCH FROM VARIOUS FUND RAISING ACTIVITIES AND PROMOTE AWARENESS OF OVARIAN CANCER THROUGH EDUCATION.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $33,300

Program Service Revenue $0

Investment Income $-8,247

Other Revenue $9,240

TOTAL REVENUE $34,293

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $12,219

TOTAL EXPENSES $12,219

Year-over-Year Comparison

	2024	2023	Change
Revenue	$34,293	$21,560	+0.6%
Expenses	$12,219	$89,082	-0.9%
Net Income	$22,074	$-67,522	-1.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BRUCE HILDRETH	PRESIDENT	20.00	Officer	$0	$0	$0
TAMI WARD	VICE PRESIDE	5.00	Officer	$0	$0	$0
SHERYL ROURKE	TREASURER	5.00	Officer	$0	$0	$0
ASHLEY HILDRETH	SECRETARY	5.00	Officer	$0	$0	$0
SHERI HILDRETH	PRESIDENT EM	N/A	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$34,293	$12,219	$169,167	$22,074
2023	$21,560	$89,082	$134,124	$-67,522
2022	$50,022	$85,501	$214,615	$-35,479
2021	$86,792	$86,163	$250,094	$629
2020	$79,714	$94,615	$249,465	$-14,901
2019	$129,737	$124,179	$264,366	$5,558
2018	$107,428	$124,299	$249,785	$-16,871

SHERIE HILDRETH OVARIAN CANCER FOUNDATION